These Healthcare stocks are trading higher:
-Outlook Therapeutics Inc (OTLK) stock is trading at $8.76, a gain of $3.03, or 52.36%, on high volume. Outlook Therapeutics Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $2.18.
-P3 Health Partners Inc (PIII) stock is trading at $1.00, a rise of $0.29, or 42.92%, on high volume. P3 Health Partners Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $4.25. P3 Health Partners Inc next reports earnings on March 29.
-Akebia Therapeutics Inc (AKBA) stock is trading at $1.77, a gain of $0.4, or 28.5%, on high volume. Akebia Therapeutics gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $4.33.
-aTyr Pharma Inc (LIFE) stock is trading at $1.93, an increase of $0.31, or 19.44%, on moderate volume. Atyr Pharma Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $24.67.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Immuneering Corp (IMRX) stock is trading at $2.06, a loss of $0.84, or 29.31%, on high volume. Immuneering Corp Cl A gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $19.14.
-Sellas Life Sciences Group Inc (SLS) stock is trading at $1.11, a decline of $0.44, or 28.71%, on high volume. Sellas Life Sciences Group Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.33. Sellas Life Sciences Group Inc next reports earnings on March 21.
-Lucy Scientific Discovery Inc (LSDI) stock is trading at $1.24, a decline of $0.44, or 26.19%, on high volume. Lucy Scientific Discovery Inc gets a Sentiment Score of Bearish from InvestorsObserver.
-Regulus Therapeutics Inc (RGLS) stock is trading at $2.11, a decline of $0.34, or 13.91%, on low volume. Regulus Therapeutics gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.50. Regulus Therapeutics next reports earnings on March 28.
Find the top stocks in the Healthcare Sector here.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
